Loading clinical trials...
Loading clinical trials...
A Phase II, Two-centre, Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Adult Subjects With Moderate to Severe Asthma
Conditions
Interventions
ASM8
Start Date
November 1, 2011
Primary Completion Date
June 1, 2012
Completion Date
May 1, 2013
Last Updated
December 3, 2012
NCT07486401
NCT07219173
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Syntara
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions